Central regions | Finance, business | Technology & innovation

HIV drug development under way, gets Skolkovo support

30 May '16
Viriom, a biomedical developer and asset of the ChemRar High Tech Center in Khimki outside Moscow, has been working on Russia’s first HIV solution which is expected to go beyond import substitution—an across-the-board goal the Russians have been pursuing in many sectors since the current crisis and western sanctions began—and offer “high potential for international commercialization.”

The new drug candidate’s safety, high efficacy and tolerance are said to have been proven during five rounds of phases 1 and 2 clinical trial testing. Phase 3 of clinical trials is currently under way in 18 AIDS prevention centers across Russia.

The Skolkovo Foundation, which is managing Russia’s most widely touted innovation hub just outside Moscow, earlier this year approved a new $2.2m grant for the next stage of the effort.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content


Latest News: Central regions
27 May '17 | Telecoms, media
23 May '17 | Energy, utilities | Technology & innovation
22 May '17 | Materials, extraction | Technology & innovation

Feature stories

17 May '17
Russian biologists and biophysicists are said to have...
21 Apr '17
6 Mar '17
Developing a photonic computer, a technology that...
Search (News archive - 21088)
Why Russians do not smile
Nano & Giga Symposium

Latest News

29 May '17
An intelligent cardiovascular diseases diagnostics...
27 May '17
Russia rose in a global ranking that assesses...
25 May '17
Russian scientists in partnership with their Korean...

Most read stories from last week

27 May '17
Russia rose in a global ranking that assesses...
29 May '17
An intelligent cardiovascular diseases diagnostics...